Your browser doesn't support javascript.
loading
Estimated pulse wave velocity is associated with all-cause mortality and cardiovascular mortality among adults with diabetes.
Wu, Li-Da; Chu, Peng; Kong, Chao-Hua; Shi, Yi; Zhu, Ming-Hui; Xia, Yi-Yuan; Li, Zheng; Zhang, Jun-Xia; Chen, Shao-Liang.
Afiliação
  • Wu LD; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Chu P; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Kong CH; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Shi Y; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhu MH; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Xia YY; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Li Z; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhang JX; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Chen SL; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Front Cardiovasc Med ; 10: 1157163, 2023.
Article em En | MEDLINE | ID: mdl-37139122
Aims: We aim to examine the association of estimated pulse wave velocity (ePWV) with all-cause and cardiovascular mortality in patients with diabetes. Methods: All of adult participants with diabetes from the National Health and Nutrition Examination Survey (NHANES) (1999-2018) were enrolled. ePWV was calculated according to the previously published equation based on age and mean blood pressure. The mortality information was obtained from the National Death Index database. Weighted Kaplan-Meier (KM) plot and weighted multivariable Cox regression was used to investigate the association of ePWV with all-cause and cardiovascular mortality risks. Restricted cubic spline was adopted to visualize the relationship between ePWV and mortality risks. Results: 8,916 participants with diabetes were included in this study and the median follow-up duration was ten years. The mean age of study population was 59.0 ± 11.6 years, 51.3% of the participants were male, representing 27.4 million patients with diabetes in weighted analysis. The increment of ePWV was closely associated with increased risks of all-cause mortality (HR: 1.46, 95% CI: 1.42-1.51) and cardiovascular mortality (HR: 1.59, 95% CI: 1.50-1.68). After adjusting for cofounding factors, for every 1 m/s increase in ePWV, there was a 43% increased risk of all-cause mortality (HR: 1.43, 95% CI: 1.38-1.47) and 58% increased of cardiovascular mortality (HR: 1.58, 95% CI: 1.50-1.68). ePWV had positive linear associations with all-cause and cardiovascular mortality. KM plots also showed that the risks of all-cause and cardiovascular mortality were significantly elevated in patients with higher ePWV. Conclusions: ePWV had a close association with all-cause and cardiovascular mortality risks in patients with diabetes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article